| 27 August 2012
The final stage of testing for a lung disease drug is finished, and
GlaxoSmithKline (GSK) said it will seek global market approval,
according to a Reuters report. Read More...
| 8 August 2012
The European Medicines Agency (EMA) has released a new guideline on clinical trials conducted to assess chronic obstructive pulmonary disease (COPD) products, updating an existing guideline regulators Read More...